Hologic, Inc. (HOLX): Price and Financial Metrics
Hologic, Inc. (HOLX)
Today's Latest Price: $67.24 USD
Updated Oct 22 12:54pm
Add HOLX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 142 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
HOLX Stock Summary
- Hologic Inc's market capitalization of $17,054,178,186 is ahead of 89.44% of US-listed equities.
- Hologic Inc's stock had its IPO on March 26, 1990, making it an older stock than 84.7% of US equities in our set.
- Over the past twelve months, HOLX has reported earnings growth of 411.9%, putting it ahead of 96.27% of US stocks in our set.
- Stocks that are quantitatively similar to HOLX, based on their financial statements, market capitalization, and price volatility, are RMD, PKI, GGG, VAR, and FTV.
- Visit HOLX's SEC page to see the company's official filings. To visit the company's web site, go to www.hologic.com.
HOLX Stock Price Chart Interactive Chart >
HOLX Price/Volume Stats
| Current price | $67.24 | 52-week high | $73.63 |
| Prev. close | $65.85 | 52-week low | $26.49 |
| Day low | $65.57 | Volume | 536,014 |
| Day high | $67.39 | Avg. volume | 2,531,971 |
| 50-day MA | $64.68 | Dividend yield | N/A |
| 200-day MA | $54.55 | Market Cap | 17.41B |
Hologic, Inc. (HOLX) Company Bio
Hologic Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company was founded in 1985 and is based in Bedford, Massachusetts.
HOLX Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $67.24 | $23.98 | -64% |
Below please find a table outlining a discounted cash flow forecast for HOLX, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Hologic Inc ranked in the 24th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 63.83%. The most interesting components of our discounted cash flow analysis for Hologic Inc ended up being:
- Hologic Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than just 0% of US stocks with positive free cash flow.
- The weighted average cost of capital for the company is 8. This value is greater than merely 21.45% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -65% |
| 1% | -64% |
| 2% | -64% |
| 3% | -64% |
| 4% | -63% |
| 5% | -63% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as HOLX, try WAT, CAH, SNN, VIVO, and WST.
Loading social stream, please wait...